Overview

Characterization of Laboratory Response to DDAVP in Adult Hemophilia A Carriers

Status:
Completed
Trial end date:
2018-06-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine how female hemophilia A carriers respond to a medication called DDAVP (Desmopressin).
Phase:
Phase 1
Details
Lead Sponsor:
Emory University
Treatments:
Deamino Arginine Vasopressin
Factor VIII